documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
3,095 rows where agency_id = "FDA" and posted_year = 2007 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Other 1,451
- Supporting & Related Material 905
- Notice 669
- Rule 50
- Proposed Rule 20
posted_year 1
- 2007 · 3,095 ✖
agency_id 1
- FDA · 3,095 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2007-P-0188-0001 | FDA | FDA-2007-P-0188 | Acknowledgement Letter from FDA DDM to Beckloff Associates, Inc. | Other | Acknowledgement Letter/Receipt | 2007-12-28T05:00:00Z | 2007 | 12 | 2015-05-07T18:08:20Z | 0 | 0 | 090000648042a763 | |||
| FDA-2006-N-0364-0001 | FDA | Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile FDA-2006-N-0364 | See FDA-2006-N-0364-0003 | Supporting & Related Material | BKG-Background Material | 2007-12-28T05:00:00Z | 2007 | 12 | 2008-06-18T17:26:35Z | 0 | 0 | 090000648045fc49 | |||
| FDA-2007-P-0178-0001 | FDA | FDA-2007-P-0178 | See FDA-2007-P-0178-0002 | Supporting & Related Material | ACK-Acknowledgement Letter (Supporting and Related Material) | 2007-12-28T05:00:00Z | 2007 | 12 | 2008-05-16T19:41:33Z | 0 | 0 | 090000648042a664 | |||
| FDA-2007-D-0257-0001 | FDA | FDA-2007-D-0257 | See Document ID FDA-2007-D-0257-0003 | Notice | 2007-12-28T00:00:00Z | 2007 | 12 | 2008-05-21T20:22:03Z | 0 | 1 | 090000648042b1c1 | ||||
| FDA-2007-D-0257-0002 | FDA | FDA-2007-D-0257 | See Document ID FDA-2007-D-0257-0004 | Other | 2007-12-28T00:00:00Z | 2007 | 12 | 2008-05-21T20:21:19Z | 0 | 1 | 090000648042b1c4 | ||||
| FDA-2007-P-0414-0005 | FDA | FDA-2007-P-0414 | Minutes of Telecon Between FDA/CDER and Dr. Victor Yu and Cristina Chiou | Other | MT-Memorandum of Telephone Conversation | 2007-12-27T05:00:00Z | 2007 | 12 | 2008-04-04T00:38:15Z | 0 | 0 | 090000648042da1a | |||
| FDA-2007-N-0313-0001 | FDA | FDA-2007-N-0313 | Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop; Request for Comments | Notice | NM-Notice of Meeting | 2007-12-26T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2008-03-01T04:59:59Z | 2008-08-15T01:38:12Z | 0 | 0 | 090000648042b70a | |
| FDA-2007-N-0445-0003 | FDA | FDA-2007-N-0445 | Number not used | Other | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-14T22:07:10Z | 0 | 1 | 090000648042ddf6 | ||||
| FDA-2007-N-0197-0002 | FDA | FDA-2007-N-0197 | Agenda - Adolescent Over-the-Counter (OTC) Drug Product Use: A Public Workshop | Other | LST-List | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-14T20:30:52Z | 0 | 0 | 090000648042a934 | |||
| FDA-2007-N-0445-0002 | FDA | FDA-2007-N-0445 | Number Not Used | Other | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-14T22:05:39Z | 0 | 1 | 090000648042ddf5 | ||||
| FDA-2007-N-0445-0004 | FDA | FDA-2007-N-0445 | Number not used | Other | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-14T22:08:41Z | 0 | 1 | 090000648042ddf7 | ||||
| FDA-2007-N-0441-0001 | FDA | FDA-2007-N-0441 | Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions; Correction | Notice | Correction | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-19T20:11:21Z | E7-24914 | 0 | 0 | 090000648042dda7 | ||
| FDA-2007-C-0044-0001 | FDA | FDA-2007-C-0044 | DSM Nutritional Products, Inc.; Filing of Color Additive Petition; Correction | Notice | NCR-Notice of Correction | 2007-12-26T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2026-01-08T20:18:17Z | 0 | 0 | 0900006480429648 | ||
| FDA-2007-N-0438-0002 | FDA | FDA-2007-N-0438 | Acknowledgment Letter from FDA DDM to Buchanan Ingersoll & Rooney PC | Other | Acknowledgement Letter/Receipt | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-11T20:21:37Z | 0 | 0 | 090000648042dd74 | |||
| FDA-2007-N-0152-0001 | FDA | FDA-2007-N-0152 | Health Claims and Qualified Health Claims; Dietary Lipids and Cancer, Soy Protein and Coronary Heart Disease, Antioxidant Vitamins and Certain Cancers, and Selenium and Certain Cancers; Reevaluation; Opportunity for Public Comment | Notice | N-Notice | 2007-12-21T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2008-02-20T04:59:59Z | 2008-07-08T18:53:47Z | 0 | 0 | 090000648042a409 | |
| FDA-2006-V-0402-0005 | FDA | FDA-2006-V-0402 | Lynne L. Rice | Other | VRA-Approval for Variance | 2007-12-21T05:00:00Z | 2007 | 12 | 2008-04-11T23:22:39Z | 0 | 0 | 0900006480460c6c | |||
| FDA-2007-P-0235-0001 | FDA | FDA-2007-P-0235 | Acknowledgment Letter from FDA CDER to Mutual Pharmaceutical Company, Inc. | Other | Acknowledgement Letter/Receipt | 2007-12-21T05:00:00Z | 2007 | 12 | 2015-09-29T13:12:16Z | 0 | 0 | 090000648042b04d | |||
| FDA-2007-V-0252-0001 | FDA | FDA-2007-V-0252 | Acknowledgement Letter to KRJ Music Work | Other | ACK-Acknowledgement Letter | 2007-12-21T05:00:00Z | 2007 | 12 | 2008-04-09T14:15:14Z | 0 | 0 | 090000648042b160 | |||
| FDA-2007-V-0356-0003 | FDA | FDA-2007-V-0356 | Lynne L. Rice - Approval for Variance | Other | VRA-Approval for Variance | 2007-12-20T05:00:00Z | 2007 | 12 | 2008-04-09T16:14:25Z | 0 | 0 | 090000648042ba0b | |||
| FDA-2007-A-0099-0002 | FDA | FDA-2007-A-0099 | Letter from FDA CDER Interim Response to AstraZeneca Ropes and Gray LLP | Other | Letter(s) | 2007-12-20T05:00:00Z | 2007 | 12 | 2014-01-21T00:25:14Z | 0 | 0 | 0900006480429d7a | |||
| FDA-2007-V-0426-0002 | FDA | FDA-2007-V-0426 | Lynne L. Rice - Approval for Variance | Other | VRA-Approval for Variance | 2007-12-20T05:00:00Z | 2007 | 12 | 2008-04-09T18:31:27Z | 0 | 0 | 090000648042dbe4 | |||
| FDA-2007-P-0243-0001 | FDA | FDA-2007-P-0243 | Acknowledgement Letter to Michael J. Dochniak | Other | ACK-Acknowledgement Letter | 2007-12-20T05:00:00Z | 2007 | 12 | 2008-07-22T22:56:16Z | 0 | 0 | 090000648042b0be | |||
| FDA-2007-N-0083-0020 | FDA | FDA-2007-N-0083 | Behind the Counter Availability of Certain Drugs; Public Meeting Wednesday, November 14, 2007 - Transcript | Supporting & Related Material | TR-Transcript | 2007-12-19T05:00:00Z | 2007 | 12 | 2008-05-12T06:10:30Z | 0 | 0 | 0900006480429b07 | |||
| FDA-2007-M-0452-0001 | FDA | FDA-2007-M-0452 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T22:48:41Z | E7-24620 | 0 | 0 | 090000648042dec7 | |
| FDA-2007-N-0083-0021 | FDA | FDA-2007-N-0083 | Behind the Counter Availability of Certain Drugs; Press Briefing on Public Meeting Wednesday, November 14, 2007 - Transcript | Supporting & Related Material | TR-Transcript | 2007-12-19T05:00:00Z | 2007 | 12 | 2008-05-12T06:12:01Z | 0 | 0 | 0900006480429b08 | |||
| FDA-2007-M-0273-0001 | FDA | FDA-2007-M-0273 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T21:15:57Z | E7-24620 | 0 | 0 | 090000648042b3c6 | |
| FDA-2007-M-0453-0001 | FDA | FDA-2007-M-0453 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-10T00:23:52Z | E7-24620 | 0 | 0 | 090000648042ded7 | |
| FDA-2007-M-0325-0001 | FDA | FDA-2007-M-0325 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-10T04:01:42Z | E7-24620 | 0 | 0 | 090000648042b804 | |
| FDA-2007-N-0382-0001 | FDA | FDA-2007-N-0382 | Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting | Notice | Meeting | 2007-12-19T05:00:00Z | 2007 | 12 | 2025-08-19T15:55:54Z | E7-24629 | 0 | 0 | 090000648042d70f | ||
| FDA-2007-M-0397-0001 | FDA | FDA-2007-M-0397 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-12T23:22:10Z | E7-24620 | 0 | 0 | 090000648042d84e | |
| FDA-2007-M-0224-0001 | FDA | FDA-2007-M-0224 | FDA | Notice | NAL-Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2008-04-04T00:35:16Z | 0 | 0 | 090000648042ae2e | ||
| FDA-2007-M-0223-0001 | FDA | FDA-2007-M-0223 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T23:33:10Z | E7-24620 | 0 | 0 | 090000648042ae1d | |
| FDA-2007-M-0093-0001 | FDA | FDA-2007-M-0093 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-13T00:37:18Z | E7-24620 | 0 | 0 | 0900006480429d20 | |
| FDA-2005-D-0013-0007 | FDA | Collection of Platelets by Automated Methods FDA-2005-D-0013 | Collection of Platelets by Automated Methods | Supporting & Related Material | Guidance | 2007-12-18T05:00:00Z | 2007 | 12 | 2020-05-14T14:55:21Z | 0 | 0 | 090000648043e53e | |||
| FDA-2007-D-0306-0002 | FDA | FDA-2007-D-0306 | International Conference on Harmonisation; Draft Guidance on Q4B | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-02-16T04:59:59Z | 2009-01-12T16:01:41Z | 0 | 0 | 090000648042b66c | |
| FDA-2007-D-0200-0002 | FDA | FDA-2007-D-0200 | International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; Availibilty | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-02-16T04:59:59Z | 2008-05-28T19:58:35Z | 0 | 0 | 090000648042abc7 | |
| FDA-2007-D-0306-0001 | FDA | FDA-2007-D-0306 | 4QB Evaluation and Recommendation of Pharmacopeial Texts for Use in the ICH Regions, Annex 3 - Guidance - Draft Guidance | Supporting & Related Material | GDL-Guidance | 2007-12-18T05:00:00Z | 2007 | 12 | 2009-01-12T16:04:33Z | 0 | 0 | 090000648042b66d | |||
| FDA-2007-D-0200-0001 | FDA | FDA-2007-D-0200 | See FDA-2007-D-0200-0003 | Supporting & Related Material | GDL-Guidance | 2007-12-18T05:00:00Z | 2007 | 12 | 2010-04-07T15:41:46Z | 0 | 0 | 090000648042abc9 | |||
| FDA-2005-D-0013-0008 | FDA | Collection of Platelets by Automated Methods FDA-2005-D-0013 | FDA | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-12-16T04:59:59Z | 2008-04-11T23:46:16Z | 0 | 0 | 090000648043e53f | |
| FDA-2007-P-0184-0001 | FDA | FDA-2007-P-0184 | Acknowledgement Letter to Judy Slome Cohain | Other | ACK-Acknowledgement Letter | 2007-12-18T05:00:00Z | 2007 | 12 | 2008-07-07T17:57:57Z | 0 | 0 | 090000648042a728 | |||
| FDA-2007-P-0110-0001 | FDA | FDA-2007-P-0110 | FDA/DDM to Physicians Committee for Responsible Medicine (PCRM) | Other | ACK-Acknowledgement Letter | 2007-12-18T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:11Z | 0 | 0 | 0900006480429e5f | |||
| FDA-2006-P-0275-0006 | FDA | Refrain from Approval of Any Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended Release100 mg & 200 mg Tablets Subsequent to ANDA 76-640 from K. V. Pharmaceuticals-CLOSED FDA-2006-P-0275 | Citizen Petition Denial from FDA CDER to KV Pharmaceutical Co | Other | Denial of Petition | 2007-12-17T05:00:00Z | 2007 | 12 | 2024-12-05T14:53:49Z | 0 | 0 | 090000648045829b | |||
| FDA-2007-P-0417-0001 | FDA | FDA-2007-P-0417 | Acknowledgement Letter to Consumers Union | Other | ACK-Acknowledgement Letter | 2007-12-17T05:00:00Z | 2007 | 12 | 2013-05-15T19:58:29Z | 0 | 0 | 090000648042da4d | |||
| FDA-2007-N-0319-0001 | FDA | FDA-2007-N-0319 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Health and Diet Survey | Notice | 30 Day Proposed Information Collection | 2007-12-17T05:00:00Z | 2007 | 12 | 2007-12-13T05:00:00Z | 2008-01-15T04:59:59Z | 2025-07-18T17:30:47Z | E7-24123 | 0 | 0 | 090000648042b7c7 |
| FDA-2007-P-0122-0052 | FDA | FDA-2007-P-0122 | FDA/CFSAN Interim Response to Compassion Over Killing & Penn Law Animal Law Project-University of Pennsylvania Law School - Letter | Other | LET-Letter | 2007-12-17T05:00:00Z | 2007 | 12 | 2008-11-26T05:47:43Z | 0 | 0 | 090000648042a1cf | |||
| FDA-2005-P-0253-0019 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e7 | |||
| FDA-2005-P-0253-0006 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442da | |||
| FDA-2005-P-0253-0005 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442d9 | |||
| FDA-2005-P-0253-0013 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e1 | |||
| FDA-2005-P-0253-0012 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e0 | |||
| FDA-2005-P-0253-0021 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e9 | |||
| FDA-2005-P-0253-0008 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442dc | |||
| FDA-2005-P-0253-0016 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e4 | |||
| FDA-2005-P-0253-0009 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:03Z | 0 | 0 | 09000064804442dd | |||
| FDA-2005-P-0253-0010 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442de | |||
| FDA-2005-P-0253-0017 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e5 | |||
| FDA-2005-P-0253-0014 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e2 | |||
| FDA-2005-P-0253-0015 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e3 | |||
| FDA-2005-P-0253-0018 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e6 | |||
| FDA-2005-P-0253-0020 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442e8 | |||
| FDA-2005-P-0253-0011 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:03Z | 0 | 0 | 09000064804442df | |||
| FDA-2005-P-0253-0007 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442db | |||
| FDA-2005-P-0253-0022 | FDA | Withdraw April 14, 2003, Warning Letter, CBER 03-010, Addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA-CLOSED FDA-2005-P-0253 | J. Shuren, Assistant Commissioner for Policy | Other | PDN-Petition Denial | 2007-12-13T05:00:00Z | 2007 | 12 | 2008-04-12T00:09:02Z | 0 | 0 | 09000064804442ea | |||
| FDA-2007-V-0421-0001 | FDA | FDA-2007-V-0421 | Acknowledgement Letter to X- Laser L. L. C. | Other | ACK-Acknowledgement Letter | 2007-12-12T05:00:00Z | 2007 | 12 | 2008-04-09T18:12:29Z | 0 | 0 | 090000648042daca | |||
| FDA-2007-V-0253-0001 | FDA | FDA-2007-V-0253 | Acknowledgement Letter to X- Laser, L. L. C. | Other | ACK-Acknowledgement Letter | 2007-12-12T05:00:00Z | 2007 | 12 | 2008-04-09T14:30:16Z | 0 | 0 | 090000648042b16e | |||
| FDA-2007-N-0441-0002 | FDA | FDA-2007-N-0441 | Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions | Notice | General Notice | 2007-12-12T05:00:00Z | 2007 | 12 | 2007-12-12T05:00:00Z | 2007-12-18T04:59:59Z | 2025-08-19T20:24:09Z | 07-6023 | 0 | 0 | 090000648042dda4 |
| FDA-2007-N-0272-0002 | FDA | FDA-2007-N-0272 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Presubmission Conferences, New Animal Drug Applications and Supporting Regulations and Guidance 152, and Form FDA 356V | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-01-11T04:59:59Z | 2025-07-23T19:31:13Z | E7-23998 | 0 | 0 | 090000648042b3bd |
| FDA-2007-N-0220-0002 | FDA | FDA-2007-N-0220 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Pharmacogenomic Data Submissions; Extension | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-01-11T04:59:59Z | 2025-08-07T22:57:55Z | E7-23996 | 0 | 0 | 090000648042adfb |
| FDA-2007-N-0383-0003 | FDA | FDA-2007-N-0383 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-01-11T04:59:59Z | 2025-08-11T16:06:25Z | E7-23977 | 0 | 0 | 090000648042d750 |
| FDA-2000-P-0152-0011 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:23Z | 0 | 0 | 09000064804d1372 | |||
| FDA-2007-C-0044-0002 | FDA | FDA-2007-C-0044 | DSM Nutritional Products, Inc.; Filing of Color Additive Petition | Notice | NFL-Notice of Filing | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2026-01-08T20:19:27Z | 0 | 0 | 0900006480429647 | ||
| FDA-2000-P-0152-0015 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:24Z | 0 | 0 | 09000064804d1378 | |||
| FDA-2007-P-0288-0002 | FDA | FDA-2007-P-0288 | FDA/CDRH to Clinical and Laboratory Standards Institute | Other | LET-Letter | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:52Z | 0 | 0 | 090000648042b4f1 | |||
| FDA-2007-P-0187-0001 | FDA | FDA-2007-P-0187 | FDA/DDM to Alston & Bird LLP | Other | ACK-Acknowledgement Letter | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:35Z | 0 | 0 | 090000648042a754 | |||
| FDA-2007-N-0080-0001 | FDA | FDA-2007-N-0080 | Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products | Notice | General Notice | 2007-12-11T05:00:00Z | 2007 | 12 | 2025-08-19T00:31:05Z | E7-24000 | 0 | 0 | 09000064804298e2 | ||
| FDA-2007-P-0115-0002 | FDA | FDA-2007-P-0115 | CDRH to Clinical and Laboratory Standards Institute | Other | LET-Letter | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:13Z | 0 | 0 | 0900006480429ef7 | |||
| FDA-2000-P-0152-0014 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:21Z | 0 | 0 | 09000064804d1376 | |||
| FDA-2000-P-0152-0013 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:18Z | 0 | 0 | 09000064804d1375 | |||
| FDA-2007-P-0187-0002 | FDA | FDA-2007-P-0187 | FDA/DDM to Alston & Bird LLP | Other | ACK-Acknowledgement Letter | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:35Z | 0 | 0 | 090000648042a759 | |||
| FDA-2007-N-0266-0001 | FDA | FDA-2007-N-0266 | Agency Information Collection Activities; Proposed Collection; Comment Request; Reports of Corrections and Removals | Notice | N-Notice | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-02-12T04:59:59Z | 2025-08-18T23:08:07Z | E7-23962 | 0 | 0 | 090000648042b37a |
| FDA-2000-P-0152-0010 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | FDA | Notice | NEC-Notice of Extension | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-02-12T04:59:59Z | 2008-04-25T01:44:24Z | 0 | 0 | 09000064804d1371 | |
| FDA-2000-P-0152-0012 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:21Z | 0 | 0 | 09000064804d1373 | |||
| FDA-2007-0629-0001 | FDA | FDA-2007-0629 | Cheeses and Related Cheese Products; Proposal to Permit the Use of Ultrafiltered Milk; Reopening of the Comment Period | Proposed Rule | NPR-Notice of Proposed Rule-Making | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-02-12T04:59:59Z | 2008-02-11T12:07:54Z | E7-23981 | 0 | 0 | 09000064803779cd |
| FDA-2000-P-0152-0016 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | Background Material | Supporting & Related Material | BKG-Background Material | 2007-12-11T05:00:00Z | 2007 | 12 | 2008-04-25T01:44:23Z | 0 | 0 | 09000064804d137b | |||
| FDA-2007-N-0087-0001 | FDA | FDA-2007-N-0087 | Agency Information Collection Activities; Proposed Collection; Comment Request; Mental Models Study of Communicating With Health Care Providers About the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women With Chronic Conditions | Notice | 60 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-02-12T04:59:59Z | 2025-09-24T22:10:20Z | E7-23976 | 0 | 0 | 0900006480429c98 |
| FDA-1978-N-0018-0629 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Envelope re: Comment from The Honorable Benjamin J. Lambert III, Senate of Virginia | Supporting & Related Material | Transmittals | 2007-12-07T05:00:00Z | 2007 | 12 | 2019-07-29T15:44:10Z | 0 | 0 | 090000648055c0f1 | |||
| FDA-1978-N-0018-0628 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Envelope re: Comment from The Honorable Benjamin J. Lambert III, Senate of Virginia | Supporting & Related Material | Transmittals | 2007-12-07T05:00:00Z | 2007 | 12 | 2019-07-29T15:47:20Z | 0 | 0 | 090000648055c0ee | |||
| FDA-2007-P-0066-0001 | FDA | FDA-2007-P-0066 | FDA/ DDM to William L. Driscoll | Other | ACK-Acknowledgement Letter | 2007-12-07T05:00:00Z | 2007 | 12 | 2008-04-04T00:37:08Z | 0 | 0 | 09000064804297f2 | |||
| FDA-2007-E-0281-0005 | FDA | FDA-2007-E-0281 | FDA/CDER to the USPTO - Letter | Other | LET-Letter | 2007-12-06T05:00:00Z | 2007 | 12 | 2026-01-06T23:23:28Z | 0 | 0 | 090000648042b44b | |||
| FDA-2007-P-0245-0003 | FDA | FDA-2007-P-0245 | FDA/CDER Interim Response to Perdue Pharma L.P. - Letter | Other | LET-Letter | 2007-12-06T05:00:00Z | 2007 | 12 | 2009-03-28T18:18:01Z | 0 | 0 | 090000648042b0f0 | |||
| FDA-2006-N-0239-0007 | FDA | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species FDA-2006-N-0239 | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Final Rule | Notice | Notice of Final Rule | 2007-12-06T05:00:00Z | 2007 | 12 | 2007-12-05T05:00:00Z | 2015-12-15T17:50:54Z | 0 | 0 | 0900006480456f42 | ||
| FDA-1978-N-0018-0626 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Envelope re: Comment from Harry R. (Bob) Purkey | Supporting & Related Material | Transmittals | 2007-12-05T05:00:00Z | 2007 | 12 | 2019-07-29T15:24:09Z | 0 | 0 | 090000648055c0e4 | |||
| FDA-2007-E-0106-0007 | FDA | FDA-2007-E-0106 | USPTO to Intervet Inc. - Letter | Other | LET-Letter | 2007-12-05T05:00:00Z | 2007 | 12 | 2008-05-02T15:45:09Z | 0 | 0 | 0900006480429e1e | |||
| FDA-2007-P-0234-0001 | FDA | FDA-2007-P-0234 | Acknowledgement Letter to Terence J. Mix, Esq. | Other | ACK-Acknowledgement Letter | 2007-12-04T05:00:00Z | 2007 | 12 | 2012-09-22T20:26:02Z | 0 | 0 | 090000648042b03f | |||
| FDA-2007-0614-0001 | FDA | FDA-2007-0614 | Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-04T05:00:00Z | 2008-02-20T04:59:59Z | 2015-12-07T15:03:20Z | E7-23292 | 0 | 0 | 090000648036fb2c |
| FDA-2007-F-0330-0001 | FDA | FDA-2007-F-0330 | General Mills, Inc.; Filing of Food Additive Petition (FAP 7M4770) | Notice | NFL-Notice of Filing | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-11-30T05:00:00Z | 2026-01-08T19:37:41Z | 0 | 0 | 090000648042b848 | ||
| FDA-2007-N-0074-0001 | FDA | FDA-2007-N-0074 | Number not used | Notice | NFL-Notice of Filing | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2008-04-04T00:35:37Z | 0 | 0 | 090000648042988b | ||
| FDA-2007-N-0379-0002 | FDA | FDA-2007-N-0379 | Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals | Rule | Direct Final Rule | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-04T05:00:00Z | 2008-02-20T04:59:59Z | 2025-07-28T22:38:38Z | E7-23294 | 0 | 0 | 090000648042c911 |
| FDA-2007-N-0379-0001 | FDA | FDA-2007-N-0379 | Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-04T05:00:00Z | 2008-02-20T04:59:59Z | 2025-07-29T09:00:10Z | E7-23292 | 0 | 0 | 090000648042c910 |
| FDA-2007-P-0182-0002 | FDA | FDA-2007-P-0182 | FDA Center for Drug and Evaluation Research Response to Sanofi Aventis - Letter | Other | LET-Letter | 2007-12-04T05:00:00Z | 2007 | 12 | 2008-07-15T23:43:46Z | 0 | 0 | 090000648042a706 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);